The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLEK.L Regulatory News (LEK)

  • There is currently no data for LEK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Suspension of trading pending annual accounts

30 Sep 2021 07:00

RNS Number : 4604N
Lekoil Limited
30 September 2021
 

30 September 2021

Lekoil Limited

("LEKOIL" or the "Company")

Suspension of trading on AIM pending publication of annual accounts

LEKOIL (AIM: LEK), the oil and gas exploration and production company with a focus on Nigeria and West Africa, provides the following update.

The Company was required to publish its audited annual report and accounts for the year ended 31 December 2020 (the "Accounts") by 30 June 2021, as required by Rule 19 of the AIM Rules for Companies (the "AIM Rules"). This deadline was subsequently extended to 30 September 2021, as announced on 17 June 2021, with the Company availing itself of the extension under the temporary measures for the publication of audited annual results for AIM companies due to Covid related delays.

The Company currently expects to publish the Accounts in the week commencing 4 October 2021, the delay being caused by administrative delays, namely a longer than expected bank account opening process. Those administrative delays have now largely been resolved.

Consequently, trading in the Company's Ordinary Shares on AIM will be suspended with effect from 7.30 a.m. on 1 October 2021 pending publication of the Accounts.

Notwithstanding the temporary suspension of trading in the Ordinary Shares, the Company will continue to make announcements as and when there are any developments that require announcement in accordance with its obligations under the AIM Rules.

 

For further information, please visit www.lekoilplc.com or contact:

SP Angel Corporate Finance LLP (Nominated Adviser and Joint Broker)

John Mackay / Jeff Keating / Stuart Gledhill / Richard Hail

 

+44 20 3470 0470

Tennyson Securities (Joint Broker)

Peter Krens / Edward Haig-Thomas

+44 20 7186 9030

 

 

Market Abuse Regulation Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ('MAR'). Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SUSEANNNADLFEFA
Date   Source Headline
17th May 20226:00 pmRNSLekoil
16th May 202210:11 amRNSOperational Update
16th May 20227:00 amRNSCorporate Update
11th May 20223:17 pmRNSNotice of GM
5th May 20227:00 amRNSLitigation summary & Response to Lekoil Nigeria
25th Apr 202211:31 amRNSRNS correction
19th Apr 202211:50 amRNSOperational Update
13th Apr 20227:00 amRNSCorporate Update
8th Apr 20227:00 amRNSResult of EGM
7th Apr 20224:06 pmRNSExtraordinary General Meeting Confirmation
7th Apr 202212:27 pmRNSCayman winding up petition
6th Apr 20229:13 amRNSNigerian injunction
1st Apr 20221:13 pmRNSLekoil Nigeria offer to purchase OPL 310 Loan
1st Apr 20227:00 amRNSCorporate Update
21st Mar 20225:59 pmRNSNotice of Extraordinary General Meeting
18th Mar 202212:43 pmRNSOperational Update
16th Mar 20221:01 pmRNSHolding(s) in Company
16th Mar 20221:00 pmRNSHolding(s) in Company
11th Mar 20224:51 pmRNSConvertible Facility update and issue of equity
11th Mar 20227:52 amRNSConvertible Facility update
9th Mar 20222:49 pmRNSConvertible Facility update
3rd Mar 202211:24 amRNSStrategic Investment and Structuring update
28th Feb 20221:58 pmRNSHolding(s) in Company
28th Feb 20221:50 pmRNSStrategic Investment and Restructuring
18th Feb 20229:18 amRNSOperational Update
16th Feb 20227:50 amRNSUpdate on legal claim
11th Feb 20227:00 amRNSHolding(s) in Company
21st Jan 20221:47 pmRNSDirector Loan - update of legal claims
19th Jan 202212:44 pmRNSDirector Loan - update of legal claims
18th Jan 202212:30 pmRNSOperational Update
18th Jan 20227:00 amRNSHolding(s) in Company
18th Jan 20227:00 amRNSHolding(s) in Company
6th Jan 20229:54 amRNSNotification of legal claim
24th Dec 20217:00 amRNSOperational Update
23rd Dec 20211:19 pmRNSOffer from Lekoil Nigeria
22nd Dec 20217:00 amRNSResult of AGM
15th Dec 20218:19 amRNSCorporate Update
7th Dec 20217:00 amRNSAnnual General Meeting attendance by telephone
6th Dec 20212:00 pmRNSCorporate update
26th Nov 202111:53 amRNSNotice of Annual General Meeting
25th Nov 202111:36 amRNSDirectorate Changes
18th Nov 20211:07 pmRNSOperational Update
27th Oct 202111:37 amRNSResults for six months ended 30 June 2021
18th Oct 202112:56 pmRNSResults for the year ended 31 December 2020
8th Oct 20215:29 pmRNSAnnual Accounts Update
1st Oct 20217:30 amRNSSuspension – Lekoil Limited
30th Sep 20217:00 amRNSSuspension of trading pending annual accounts
24th Sep 20213:36 pmRNSCivil Action
22nd Sep 20217:00 amRNSInterim Results Reporting Timeline
15th Sep 20211:00 pmRNSCorporate and Operational Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.